Skip to main content
Clinical Trials/TCTR20231021001
TCTR20231021001
Not yet recruiting
Phase 1

The efficacy of autologous Platelet-Rich Plasma (PRP) for the adjuvant treatment of Frontal Fibrosing Alopecia (FFA), a randomized, controlled trial, split-scalp study

Ratchadapiseksompotch Research Fund0 sites30 target enrollmentOctober 21, 2023

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Frontal Fibrosing Alopecia
Sponsor
Ratchadapiseksompotch Research Fund
Enrollment
30
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 21, 2023
End Date
July 30, 2024
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Ratchadapiseksompotch Research Fund

Eligibility Criteria

Inclusion Criteria

  • 1\. The subject is aged \> 18 years 2\. FFA patient who has active disease 3\. Subjects who can comply with trial procedures and are available for the duration of follow\-up

Exclusion Criteria

  • 1\. pregnancy of breast feeding patient
  • 2\. Subjects who has abnormal coagulation
  • 3\. Subjects who can not comply with trial procedures and are available for the duration of follow\-up

Outcomes

Primary Outcomes

Not specified

Similar Trials